Jeil Pharmaceutical Co.,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	34,075	32,991	31,446	25,963	3,893	13,515
Short-Term Investments	3,504	2,667	142.46	2,040	2,695	4.76
Cash & Short-Term Investments	37,579	35,658	31,589	28,003	6,588	13,520
Cash Growth	3.24%	12.88%	12.80%	325.06%	-51.27%	-
Accounts Receivable	152,317	150,955	137,807	129,424	141,176	141,517
Other Receivables	13,858	15,171	15,454	15,265	15,747	20,367
Receivables	166,175	166,126	153,262	146,689	156,922	161,883
Inventory	114,432	109,768	99,151	102,458	109,311	84,071
Prepaid Expenses	218.62	327.84	291.88	186.71	167.88	132.54
Other Current Assets	5,817	5,167	7,348	7,336	4,524	4,527
Total Current Assets	324,222	317,046	291,641	284,672	277,513	264,134
Property, Plant & Equipment	133,025	137,041	138,402	125,710	115,547	120,438
Long-Term Investments	7,466	7,343	6,798	5,032	1,920	1,090
Other Intangible Assets	5,052	4,320	3,888	3,762	4,095	4,324
Long-Term Accounts Receivable	-0	-0	0	0	-	-
Long-Term Deferred Tax Assets	7,133	5,359	172.39	1,452	3,321	2,185
Long-Term Deferred Charges	8,827	8,561	5,494	-	-	-
Other Long-Term Assets	7,377	7,656	10,496	5,858	7,267	8,224
Total Assets	493,103	487,326	456,892	426,486	409,663	400,396
Accounts Payable	139,247	144,338	151,641	153,084	143,363	149,576
Accrued Expenses	174.11	160.74	99.91	29.33	24.88	5.5
Short-Term Debt	71,169	64,772	40,576	24,166	30,419	6,000
Current Portion of Long-Term Debt	-	-	2,500	6,125	6,125	6,125
Current Portion of Leases	1,981	1,946	1,832	1,915	1,598	1,881
Current Income Taxes Payable	2,951	448.24	1,049	114.57	3,432	4,245
Other Current Liabilities	80,939	92,710	62,667	36,509	33,096	40,687
Total Current Liabilities	296,460	304,375	260,366	221,943	218,058	208,519
Long-Term Debt	-	-	3,999	8,977	7,656	13,781
Long-Term Leases	3,191	4,452	5,443	6,617	3,506	4,636
Other Long-Term Liabilities	850.38	938.52	23,170	20,339	459.46	346.11
Total Liabilities	309,352	316,499	293,003	259,139	237,184	231,541
Common Stock	7,352	7,352	7,352	7,352	7,352	7,352
Additional Paid-In Capital	155,296	155,296	155,296	155,296	149,117	149,115
Retained Earnings	-53,976	-19,660	-20,321	-10,414	2,841	-1,180
Treasury Stock	-4,829	-4,829	-4,829	-4,432	-3,622	-3,307
Comprehensive Income & Other	64,853	20,410	20,410	20,410	16,706	16,874
Total Common Equity	168,697	158,570	157,909	168,213	172,394	168,855
Minority Interest	15,053	-1,538	-2,312	-866.16	85.04	-
Shareholders' Equity	183,751	170,828	163,889	167,347	172,479	168,855
Total Liabilities & Equity	493,103	487,326	456,892	426,486	409,663	400,396
Total Debt	76,341	71,170	54,350	47,800	49,304	32,424
Net Cash (Debt)	-38,761	-35,513	-22,761	-19,797	-42,716	-18,904
Net Cash Per Share	-2660.07	-2437.13	-1561.68	-1355.11	-2922.88	-1288.17
Filing Date Shares Outstanding	14.57	14.57	14.57	14.58	14.61	14.61
Total Common Shares Outstanding	14.57	14.57	14.57	14.58	14.61	14.61
Working Capital	27,762	12,671	31,275	62,729	59,455	55,615
Book Value Per Share	11577.20	10882.20	10836.83	11533.52	11800.20	11553.97
Tangible Book Value	163,645	154,250	154,021	164,451	168,299	164,531
Tangible Book Value Per Share	11230.49	10585.71	10570.02	11275.56	11519.87	11258.11
Land	40,683	40,613	40,586	30,106	23,821	23,821
Buildings	66,552	103,864	103,864	102,213	102,747	102,747
Machinery	10,849	88,622	82,315	76,560	72,000	69,396
Construction In Progress	-	3,070	3,717	2,390	584.93	518.46

Source: S&P Capital IQ. Standard template. Financial Sources.